Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.

Detailed Quote for Roche Holding Ltd ADR (Sponsored) (RHHBY)

Detailed Quote for Roche Holding Ltd ADR (Sponsored) (RHHBY)

Sector News | Topic News
News for Roche Holding Ltd ADR (Sponsored) (RHHBY)
Fri, May 24, 2019
10:28 AM FDA OKs first Zika diagnostic test in U.S. - SeekingAlpha
9:06 AM Wanna Reduce Risk?\u00A0 Invest In Recurring Revenue - SeekingAlpha
Thu, May 23, 2019
10:00 AM Roche receives FDA clearance to expand testing menu on cobas 6800/8800 Systems for sexually transmitted diseases - PR Newswire
Wed, May 22, 2019
3:00 PM Aerpio Pharmaceuticals: Eye Spy An Opportunity - SeekingAlpha
9:13 AM Synlogic teams up with Roche in potential combo therapy for solid tumors - SeekingAlpha
Tue, May 21, 2019
2:30 PM Pfizer: Added Value For A Defensive Pharma Portfolio - SeekingAlpha
Mon, May 20, 2019
8:36 AM Outlook poised to add to ONS-5010-stoked rally, up 30% premarket - SeekingAlpha
7:17 AM Merger Arbitrage Mondays - Supercomputer Company Cray Acquired By Hewlett Packard Enterprise - SeekingAlpha
Fri, May 17, 2019
10:00 AM Stocks to Watch: Roche Holding Ltd ADR (Sponsored) (OTCQX:RHHBY) Up +2.29% Thursday - StockStreetNews
10:00 AM Stocks to Watch: Roche Holding Ltd ADR (Sponsored) (OTCQX:RHHBY) Up +2.29% Thursday - StreetSignals
Thu, May 16, 2019
7:47 AM Roche's entrectinib shows positive action in early-stage cancer study - SeekingAlpha
1:03 AM Roche announces FDA approval for Venclexta plus Gazyva for people with previously untreated chronic lymphocytic leukaemia - Thomson Reuters ONE
1:00 AM Roche's personalised medicine entrectinib shrank tumours harbouring NTRK, ROS1 or ALK gene fusions in children and adolescents - Thomson Reuters ONE
Wed, May 15, 2019
5:00 PM Genentech's Personalized Medicine Entrectinib Shrank Tumors Harboring NTRK, ROS1 or ALK Gene Fusions in Children and Adolescents - Business Wire
3:21 PM FDA OKs expanded label for AbbVie and Roche's Venclexta - SeekingAlpha
2:20 PM Genentech Announces FDA Approval for Venclexta Plus Gazyva for People With Previously Untreated Chronic Lymphocytic Leukemia - Business Wire
12:49 PM NeuClone to launch clinical development of Stelara biosimilar - SeekingAlpha
12:08 PM Roche's Kadcyla Approval Will Have A Big Impact On Breast Cancer Patients - SeekingAlpha
Tue, May 14, 2019
10:04 PM Novartis Gears Up For Zolgensma Approval - SeekingAlpha
1:03 AM New Roche test aids clinicians in accelerating tuberculosis diagnosis and treatment by detecting antimicrobial resistance within the world's leading cause of infectious disease deaths - Thomson Reuters ONE
More News for RHHBY >>